Jones Financial Companies
XGN icon

Jones Financial Companies’s Exagen XGN Stock Holding History

Jones Financial Companies’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$916 Hold
200
– – ﹤0.01% 4621
2026
Q1 		$536 Hold
200
– – ﹤0.01% 4475
2025
Q4 		$1.22K Buy
+200
New +$1.82K ﹤0.01% 3969

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
Silvercrest Asset Management
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Jones Financial Companies's XGN Position: Q2 2026 in Review

Jones Financial Companies held its Exagen (XGN) position steady in Q2 2026 at 200 shares worth $916. The position accounts for ﹤0.01% of the portfolio, ranked #4621.

Jones Financial Companies first reported a position in XGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.22K in Q4 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Jones Financial Companies held 200 shares of Exagen worth $916 as of Q2 2026.
  • Jones Financial Companies left its Exagen share count unchanged in Q2 2026.
  • Exagen made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4621 holding.
  • Jones Financial Companies first reported a position in Exagen in Q4 2025 and has held it in 3 quarters since.
  • Jones Financial Companies's Exagen position peaked at $1.22K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.